Cargando…
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities
In light of the disappointing termination of clinical trials with potent complex I inhibitors, such as IACS-010759, justification for oxidative phosphorylation inhibitors and mitochondrial targeting strategies has been called into question. Consideration of these agents’ potency, tissue selectivity...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491675/ https://www.ncbi.nlm.nih.gov/pubmed/37563220 http://dx.doi.org/10.1038/s41416-023-02394-9 |